Posttransplantation dialysis-associated infections: Morbidity and impact on outcome in liver transplant recipients
Authors:
- 1 February 2001
- journal article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 7 (2) , 100-105
Abstract
The aim of this study is to assess the predictors, impact on infectious morbidity, and outcome of posttransplantation dialysis in liver transplant recipients and to compare the results with data from patients who did not require dialysis after transplantation. The study sample included 176 consecutive patients undergoing liver transplantation; the median follow-up was 4.3 years. All patients were administered tacrolimus as primary immunosuppression. Overall, 16% (28 of 176 patients) of the patients required dialysis after transplantation. Patients requiring dialysis had significantly greater pretransplantation creatinine levels (2.4 v 1.2 mg/dL; P = .009), were more likely to require pretransplantation dialysis (21% v 1%; P = .0001), and had a greater rate of biopsy-proven rejection episodes (50%, 14 of 28 episodes v 20%, 30 of 148 episodes; P = .0009) and longer posttransplantation intensive care unit lengths of stay (P = .0001). The incidence of infections (91% v 41%; P = .0001) and episodes of infection per patient (2.4 v 0.7 episodes; P = .0001) were significantly greater in patients undergoing dialysis compared with those not undergoing dialysis. There was no difference in the frequency of cytomegalovirus (CMV) infection or disease; however, bacterial infections (87% v 31%; P = .0001) and invasive fungal infections (39% v 7%; P = .0001) were significantly more likely to occur in patients requiring dialysis. In logistic regression, dialysis (P = .0006) and CMV infection (P = .007) were independent significant predictors of major infections. Overall survival (assessed by Kaplan-Meier probability) was less in patients undergoing dialysis compared with those not undergoing dialysis (P = .0001). Among dialyzed patients, only 10% of those who survived had an invasive fungal infection compared with 46% of those who died (P = .08); 5 of 6 patients died within 1 month of the fungal infection. The need for dialysis portended a grave outcome in liver transplant recipients and identified a subgroup of patients at a significantly greater risk for major infections, particularly fungal infections, after liver transplantation.Keywords
This publication has 13 references indexed in Scilit:
- LATE-ONSET RENAL FAILURE AFTER LIVER TRANSPLANTATION: ROLE OF POSTTRANSPLANT ALCOHOL USE1Transplantation, 2000
- Continuous venovenous hemodialysis treatment in critically ill patients after liver transplantationKidney International, 1999
- INFECTIOUS COMPLICATIONS OCCURRING IN LIVER TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETILTransplantation, 1998
- Invasive Fungal Infections in Liver Transplant Recipients Receiving Tacrolimus as the Primary Immunosuppressive AgentClinical Infectious Diseases, 1997
- OUTCOME OF PATIENTS WITH RENAL INSUFFICIENCY UNDERGOING LIVER OR LIVER-KIDNEY TRANSPLANTATION1,2Transplantation, 1996
- Successful treatment of cryptococcal meningitis with amphotericin B colloidal dispersion: report of four casesAntimicrobial Agents and Chemotherapy, 1995
- IMPACT OF PRETRANSPLANT RENAL FUNCTION ON SURVIVAL AFTER LIVER TRANSPLANTATIONTransplantation, 1995
- INFECTIOUS COMPLICATIONS IN LIVER TRANSPLANT RECIPIENTS ON TACROLIMUS Prospective Analysis of 88 Consecutive Liver TransplantsTransplantation, 1994
- High-Dose Acyclovir Compared with Short-Course Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Liver Transplant RecipientsAnnals of Internal Medicine, 1994
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988